BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
BIOVIE INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$1.37+0.17 (+14.17%)
Close on Oct 19, 2026
- Market cap
- $10.86M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Biovie has not reported a dividend
No dividend per share appears in Biovie's annual filings since fiscal 2013.